SCHEMBL4306146

SCHEMBL4306146

CC(C)(C)OC(=O)NC1CCNCC1.O=Cc1ccc2ccccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.45
KDM1A O60341 1/20 0.42
MAOB P27338 1/20 0.42
EPHX2 P34913 1/20 0.42
CKS1B P61024 1/20 0.41
SKP1 P63208 1/20 0.41
SKP2 Q13309 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMO Q99835 1/20 0.40
KCNA3 P22001 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OGFRL1 Q5TC84 1/20 0.40
DRD2 P14416 2/20 0.38
SSTR4 P31391 2/20 0.38
SSTR1 P30872 1/20 0.38
PARP1 P09874 1/20 0.38
ACACB O00763 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL28191155 0.83 PDE10A (0.49) PDE10AKDM1AMAOBEPHX2CKS1B
SCHEMBL4300021 0.76 CYP2A6 (0.47) KDM1AMAOBEPHX2CKS1BSKP1
SCHEMBL4304869 0.76 PIM1 (0.35) KDM1AMAOBEPHX2CKS1BSKP1
SCHEMBL4296620 0.76 GAA (0.37) KDM1AMAOBEPHX2CKS1BSKP1
Formic Acid SCHEMBL7216484 0.75 BTK (0.48) KDM1AMAOBEPHX2KMT2AL3MBTL1
SCHEMBL56856 0.75 EPHX1 (0.53) KDM1AMAOBEPHX2KMT2AL3MBTL1
Ammonia Solution, Strong SCHEMBL15021680 0.74 EPHX1 (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1
Hydrochloric Acid SCHEMBL4158527 0.74 EPHX1 (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1
Water SCHEMBL27795194 0.74 EPHX1 (0.52) KDM1AMAOBEPHX2KMT2AL3MBTL1
SCHEMBL16666162 0.73 PDE10A (0.43) PDE10AKDM1AMAOBCKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071592-B2 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2011-12-06 US disclosed
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES GLAXO GROUP LIMITED (GB) 2009-10-29 US disclosed
EP-1992628-A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES ETFA, NQO2, GNAQ PDE10A 2837/4885KDM1A 3919/4885MAOB 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.